{
    "Trade/Device Name(s)": [
        "QIAstat-Dx GI Panel 2 Mini B"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K250324",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220062"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH"
    ],
    "Summary Letter Date": "February 28, 2025",
    "Summary Letter Received Date": "February 5, 2025",
    "Submission Date": "February 4, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assay"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Campylobacter",
        "Shigella",
        "Shiga-like toxin Escherichia coli (STEC)",
        "Salmonella",
        "Yersinia enterocolitica"
    ],
    "Specimen Type(s)": [
        "Preserved stool"
    ],
    "Specimen Container(s)": [
        "Para-Pak C&S",
        "FecalSwab"
    ],
    "Instrument(s)/Platform(s)": [
        "QIAstat-Dx Analyzer 1.0"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time RT-PCR",
        "Nucleic acid extraction",
        "Microfluidic sample preparation"
    ],
    "Methodologies": [
        "Multiplex nucleic acid testing",
        "Real-time RT-PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for QIAGEN QIAstat-Dx GI Panel 2 Mini B multiplex nucleic acid assay for simultaneous qualitative detection of five bacteria from stool using QIAstat-Dx Analyzer 1.0",
    "Indications for Use Summary": "Qualitative detection and identification of nucleic acids from Campylobacter, Shigella, Shiga-like toxin Escherichia coli (STEC), Salmonella, and Yersinia enterocolitica in preserved stool samples from individuals with gastrointestinal infection symptoms, as an aid in diagnosis in conjunction with other data",
    "fda_folder": "Microbiology"
}